Selected Abstracts

Cerebrospinal fluid derived from progressive multiple sclerosis patients induces demyelinating lesions in the mouse CNS

M. Cristofanilli, B. Cymring, H. Rosenthal, B. Xie, S.A. Sadiq; Presented Nov. 11, 2013 at the 2013 annual Society for Neuroscience Conference.

Persistence of Cerebrospinal Fluid Oligoclonal Bands after Natalizumab Treatment of Multiple Sclerosis Patients

J.W. Stark, D. Koffler, and S.A. Sadiq. Presented at the 65th annual meeting of the American Academy of Neurology, held March 16-23, 2013 in San Diego, CA.

Read Abstract

Correlation between oxidative stress and chemokines in the cerebrospinal fluid of multiple sclerosis patients

H.J. Ray, D. Lee, F. Mir, and S. Sadiq..Presented at the 65th annual meeting of the American Academy of Neurology, held March 16-23, 2013 in San Diego, CA.

Read Abstract

A Proof of principle study: Diagnosing MS by analyzing the CSF cell transcriptome

B.H. Yoon, A. Mueller, E. Franzova, and S. Sadiq. Presented at the 65th annual meeting of the American Academy of Neurology, held March 16-23, 2013 in San Diego, CA.

Identification of CSF biomarkers of cognitive impairment and cerebellar dysfunction in multiple sclerosis

L.H. Bell, V.K. Harris, and S.A. Sadiq. Presented at the 65th annual meeting of the American Academy of Neurology, held March 16-23, 2013 in San Diego, CA.

Read Abstract

Transglutaminase 6 antibodies are elevated in the serum of multiple sclerosis patients

M. Cristofanilli, J. Goldberg, D. Bates, and S.A. Sadiq. Presented at the 2012 meeting of the Society for Neuroscience, held October 13-17, 2013 in New Orleans, LA.

Read Abstract

Do Immunological Profiles of the Cerebrospinal Fluid Correlate with Disease Severity in Multiple Sclerosis?

Edward Brydon, PhD, Emma Marszal, BA and Saud Sadiq, MD, MB. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Safety of Long-Term Intrathecal Methotrexate Therapy in Progressive Forms of Multiple Sclerosis

James Stark, Deirdre Dulak, and Saud A. Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Accurate Risk Assessment for the Development of PML in Natalizumab Treated MS Patients Requires CSF Analysis

Peggy Bettin, Jerry Lin, and Saud A. Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Neuroketals in the cerebrospinal fluid of multiple sclerosis patients

Donald Lee, Fozia Mir and Saud Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.